What Researchers Did
Researchers provided an update on provider participation and data capture within the US Wound Registry and its Hyperbaric Oxygen Therapy Registry, which serve for national benchmarking and quality measurement.
What They Found
Since January 2012, the US Wound Registry captured data from 917,758 clinic visits for 199,158 patients, with 3,697 undergoing hyperbaric oxygen therapy. Among 27,404 patients with 62,843 diabetic foot ulcers, 9,908 (15.7%) received HBO₂ therapy, with a benchmark healing rate of 7.3% for 1,000 DFUs and an average of 28 treatments per patient between 2016 and 2018.
What This Means for Canadian Patients
While this study focuses on a US registry, the data on hyperbaric oxygen therapy for diabetic foot ulcers could inform treatment protocols and quality improvement initiatives. Implementing similar national registries in Canada could help standardize care, benchmark outcomes, and improve the quality of hyperbaric medicine services for Canadian patients.
Canadian Relevance
This study directly concerns a US-based registry and does not have a direct Canadian connection. However, the principles of national registries for quality measurement could be relevant for Canadian healthcare systems.
Study Limitations
The study primarily describes the status and utility of a US-based registry, and does not evaluate the clinical efficacy of hyperbaric oxygen therapy or address potential biases in data reporting.